A biotechnology corporation
Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement; Issues relating to Prescription Drug User Fee Act and ASP +6 and Part B Demo; Issues related to comparative effectiveness and follow-on biologics; Issues related to FDA repeal of Avastin;  Issues related to coverage of Lucentis and Avastin; Issues related to 340B; Issues related to the 21st Century Cures Act,  H.R. 6. Trade related issues. Tax related issues. Intellectual Property and Process Patent Issues. Issues related to the Vice President's National Cancer Moonshot Initiative.
MMM - Medicare/Medicaid TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FORBES-TATE
777 6th Street NW, 8th Floor, Washington, DC, 20001, US
JEFFREY FORBES JERRY DRISCOLL ELIZABETH GREER JEFFREY FORBES JERRY DRISCOLL ELIZABETH GREER JEFFREY FORBES JERRY DRISCOLL ELIZABETH GREER JEFFREY FORBES ELIZABETH GREER JERRY DRISCOLL JEFFREY FORBES ELIZABETH GREER JERRY DRISCOLL